Abstract
Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) emerged in Wuhan, China, and was quickly isolated following cases of viral acute respiratory distress syndrome (ARDS). Understanding of the clinical constellation associated with SARS-CoV-2 expanded to include cardiovascular, neurological, and systemic inflammatory manifestations, and disease following infection with SARS-CoV-2 became collectively called Corona Virus Disease - 2019 (COVID-19).
Highlights
Severe Acute Respiratory Syndrome Corona Virus 2 (SARSCoV-2) emerged in Wuhan, China, and was quickly isolated following cases of viral acute respiratory distress syndrome (ARDS)
Understanding of the clinical constellation associated with SARS-CoV-2 expanded to include cardiovascular, neurological, and systemic inflammatory manifestations, and disease following infection with SARS-CoV-2 became collectively called Corona Virus Disease - 2019 (COVID-19) [1]
As COVID-19 grew to pandemic proportions, local and national mitigation measures to reduce SARS-CoV-2 transmission were adopted
Summary
Severe Acute Respiratory Syndrome Corona Virus 2 (SARSCoV-2) emerged in Wuhan, China, and was quickly isolated following cases of viral acute respiratory distress syndrome (ARDS). Though critical for the disruption of viral transmission, an emerging consequence of these collective measures has been indirect increases in mortality and morbidities associated with other causes, including treatment and prevention programs for human immunodeficiency virus (HIV), malaria, and tuberculosis (TB). HIV, TB, and malaria control programs often require patients to report to certain clinics or supply dissemination locations (e.g., needle exchange sites or bed net distribution points).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
